Align Technology, Inc. ALGN
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Align Technology, Inc. (ALGN) Free cash flow
Align Technology, Inc.'s free cash flow for fiscal 2025 was $490.8M, down 21.2% from $622.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was $675.6M. Over the past ten years it has ranged from $177.1M (fiscal 2016) to $771.4M (fiscal 2021); the current reading is higher than 55% of that period. Align Technology, Inc. ranks 8th of 55 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $490.8M | (21.18%) |
| FY2024 | $622.7M | 2.40% |
| FY2023 | $608.1M | 119.65% |
| FY2022 | $276.8M | (64.12%) |
| FY2021 | $771.4M | 52.08% |
| FY2020 | $507.3M | (15.11%) |
| FY2019 | $597.6M | 80.33% |
| FY2018 | $331.4M | 36.45% |
| FY2017 | $242.8M | 37.14% |
| FY2016 | $177.1M | (4.05%) |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $199.1M | 65.56% |
| Mar 2026 | $120.3M | (35.78%) |
| Dec 2025 | $187.3M | 10.83% |
| Sep 2025 | $169.0M | 57.65% |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BAX Baxter International Inc. compare | $815.0M |
| COO The Cooper Companies, Inc. compare | $678.0M |
| ALGN Align Technology, Inc. | $675.6M |
| AVTR Avantor, Inc. compare | $454.7M |
| ATR AptarGroup, Inc. compare | $314.6M |
| BLCO Bausch + Lomb Corporation compare | $137.0M |
| RGEN Repligen Corporation compare | $110.3M |
| STVN Stevanato Group S.p.A. compare | −$34.7M |
| SOLV Solventum Corporation compare | −$118.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ALGN
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement